Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.44 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.44 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.44 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | XDH | P47989 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.43 |
| ▸ | MAPT | P10636 | 6/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25260378 | 0.88 | HDAC1 (0.61) | HDAC1PIK3CAPIK3CBPIK3CGPI4KB | |
| SCHEMBL15697489 | 0.80 | HDAC1 (0.61) | HDAC1PIK3CAPIK3CBPIK3CGPI4KB | |
| SCHEMBL19029299 | 0.80 | HDAC1 (0.50) | HDAC1PIK3CAPIK3CBPIK3CGPI4KB | |
| SCHEMBL6299396 | 0.80 | HDAC1 (0.50) | HDAC1PIK3CAPIK3CBPIK3CGPI4KB | |
| SCHEMBL31095469 | 0.78 | HDAC1 (0.52) | HDAC1PIK3CAPIK3CBPIK3CGPI4KB | |
| SCHEMBL1883961 | 0.78 | HDAC1 (0.60) | HDAC1PIK3CAPIK3CBPIK3CGPI4KB | |
| SCHEMBL18936014 | 0.78 | HDAC1 (0.49) | HDAC1PIK3CAPIK3CBPIK3CGPI4KB | |
| SCHEMBL24673803 | 0.78 | HDAC1 (0.49) | HDAC1PIK3CAPIK3CBPIK3CGPI4KB | |
| SCHEMBL9612670 | 0.77 | CLK1 (0.59) | HDAC1PIK3CAPIK3CBPIK3CGPI4KB | |
| SCHEMBL12365630 | 0.76 | HDAC1 (0.47) | HDAC1PIK3CAPIK3CBPIK3CGPI4KB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340570-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2022-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220340570-A1 | IRAK DEGRADERS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | HDAC1 502/4885PIK3CA 142/4885PIK3CB 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.